Laparoscopic Surgery for Median Arcuate Ligament Syndrome (MALS): A Prospective Cohort of 52 Patients.


Journal

Vascular health and risk management
ISSN: 1178-2048
Titre abrégé: Vasc Health Risk Manag
Pays: New Zealand
ID NLM: 101273479

Informations de publication

Date de publication:
2022
Historique:
received: 02 12 2021
accepted: 17 02 2022
entrez: 31 3 2022
pubmed: 1 4 2022
medline: 2 4 2022
Statut: epublish

Résumé

The selection of patients with MALS for surgical treatment depends upon the reliability of the symptom interpretation and the diagnostic work-up. We aimed to follow up the results of the laparoscopic decompression of the patients with MALS. In a single-center, 52 consecutive MALS patients were followed-up, prospectively, after transperitoneal laparoscopic decompression. MALS was diagnosed with a computed tomography angiography (CTA) verified stenosis, ≥50% of the celiac artery (CA), and with duplex ultrasound, a peak systolic velocity (PSV) ≥2.0 m/s. Postoperative, CTA, and duplex ultrasound were performed, and the patients were followed-up at 3, 6, 12 months, and yearly after that. Mean age of the patients was 47 ±21 years, and 65% were females. The patients had a mean weight loss of 8.4 ±7.2 kg. Fifty-one patients had the laparoscopic operation with a mean operation time of 102 ± 28 minutes. Forty-seven patients (90%) achieved relief from the symptoms either completely (67%) or partially (23%) at 3-6 months of follow-up. Significant improvement in postoperative PSV was found compared to the preoperative values, p<0.001. Five patients (10%) with no immediate effect of the operation, but two of them became free from symptoms during the mean study follow-up of 2.4 ± 2 years. Five patients (10%) had operative complications, including one trocar injury to the liver, one pneumothorax, and three cases of bleeding from the branches of CA. Two patients died of cancer disease during the study period. Only two patients (4%) had symptoms relapse, both later treated successfully. Laparoscopic transperitoneal decompression provides most of the patients a persistent relief from MALS symptoms.

Sections du résumé

Background UNASSIGNED
The selection of patients with MALS for surgical treatment depends upon the reliability of the symptom interpretation and the diagnostic work-up. We aimed to follow up the results of the laparoscopic decompression of the patients with MALS.
Patients and Methods UNASSIGNED
In a single-center, 52 consecutive MALS patients were followed-up, prospectively, after transperitoneal laparoscopic decompression. MALS was diagnosed with a computed tomography angiography (CTA) verified stenosis, ≥50% of the celiac artery (CA), and with duplex ultrasound, a peak systolic velocity (PSV) ≥2.0 m/s. Postoperative, CTA, and duplex ultrasound were performed, and the patients were followed-up at 3, 6, 12 months, and yearly after that.
Results UNASSIGNED
Mean age of the patients was 47 ±21 years, and 65% were females. The patients had a mean weight loss of 8.4 ±7.2 kg. Fifty-one patients had the laparoscopic operation with a mean operation time of 102 ± 28 minutes. Forty-seven patients (90%) achieved relief from the symptoms either completely (67%) or partially (23%) at 3-6 months of follow-up. Significant improvement in postoperative PSV was found compared to the preoperative values, p<0.001. Five patients (10%) with no immediate effect of the operation, but two of them became free from symptoms during the mean study follow-up of 2.4 ± 2 years. Five patients (10%) had operative complications, including one trocar injury to the liver, one pneumothorax, and three cases of bleeding from the branches of CA. Two patients died of cancer disease during the study period. Only two patients (4%) had symptoms relapse, both later treated successfully.
Conclusion UNASSIGNED
Laparoscopic transperitoneal decompression provides most of the patients a persistent relief from MALS symptoms.

Identifiants

pubmed: 35356549
doi: 10.2147/VHRM.S350841
pii: 350841
pmc: PMC8959725
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

139-151

Informations de copyright

© 2022 Kazmi et al.

Déclaration de conflit d'intérêts

The authors report no conflicts of interest in this work.

Références

J R Soc Med. 1993 May;86(5):264-6
pubmed: 8505748
Eur J Vasc Endovasc Surg. 2017 Apr;53(4):460-510
pubmed: 28359440
Wideochir Inne Tech Maloinwazyjne. 2018 Dec;13(4):539-541
pubmed: 30524627
Clin Transl Gastroenterol. 2020 Aug;11(8):e00200
pubmed: 32955192
Vasc Health Risk Manag. 2020 Aug 10;16:331-341
pubmed: 32982262
Langenbecks Arch Surg. 2009 Nov;394(6):1085-92
pubmed: 19506899
Am J Roentgenol Radium Ther Nucl Med. 1965 Nov;95(3):731-44
pubmed: 5844938
J Gastrointest Surg. 2018 Apr;22(4):713-721
pubmed: 29185149
J Vasc Surg. 2012 Sep;56(3):869-73
pubmed: 22743019
Korean J Radiol. 2001 Jan-Mar;2(1):8-13
pubmed: 11752963
Ann Vasc Surg. 2016 Jan;30:22-7
pubmed: 26365109
J Vasc Surg. 2009 Jul;50(1):124-33
pubmed: 19563960
J Vasc Surg. 2014 Jul;60(1):111-9, 119.e1-2
pubmed: 24650741
JAMA Surg. 2016 May 1;151(5):471-7
pubmed: 26934394
Ann Chir Gynaecol Fenn. 1963;52:547-50
pubmed: 14083857
J Vasc Surg. 1993 Jan;17(1):79-84; discussion 85-6
pubmed: 8421345
Anesth Analg. 1995 Feb;80(2):290-5
pubmed: 7818115
J Vasc Surg. 2000 Oct;32(4):814-7
pubmed: 11013046
J Vasc Surg. 2020 Jun;71(6):2170-2176
pubmed: 31882314
JSLS. 2020 Apr-Jun;24(2):
pubmed: 32518479
Ann Vasc Surg. 2010 Nov;24(8):1094-101
pubmed: 21035701
J Vasc Surg. 2009 Jul;50(1):140-7
pubmed: 19563962
J Vasc Surg. 2006 Aug;44(2):277-81
pubmed: 16890853
Int J Med Robot. 2018 Aug;14(4):e1919
pubmed: 29745060

Auteurs

Syed Sajid Hussain Kazmi (SSH)

Department of Vascular Surgery, Division of Cardiovascular and Pulmonary Diseases, Oslo University Hospital, Ullevål, Oslo, Norway.
Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.

Nathkai Safi (N)

Department of Vascular Surgery, Division of Cardiovascular and Pulmonary Diseases, Oslo University Hospital, Ullevål, Oslo, Norway.
Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.

Simen Tveten Berge (ST)

Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
Department of Vascular Surgery, Innlandet Hospital Trust, Hamar, Norway.

Marryam Kazmi (M)

Department of Vascular Surgery, Division of Cardiovascular and Pulmonary Diseases, Oslo University Hospital, Ullevål, Oslo, Norway.
Faculty 2, Poznan University of Medical Sciences, Poznan, Poland.

Jon Otto Sundhagen (JO)

Department of Vascular Surgery, Division of Cardiovascular and Pulmonary Diseases, Oslo University Hospital, Ullevål, Oslo, Norway.

Jonny Hisdal (J)

Department of Vascular Surgery, Division of Cardiovascular and Pulmonary Diseases, Oslo University Hospital, Ullevål, Oslo, Norway.
Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH